Search
Displaying 431–440 of 1042 results
-
RD Fund Announces Series B Financing Behind SalioGen Therapeutics
In the PressInvestment in new portfolio company furthering genetic medicine approaches for individuals affected by retinal degenerative diseases.
-
In the Press
Series B new investors included Fidelity Management & Research Company LLC, funds and accounts advised by T. Rowe Price Associates, Inc., D1 Capital Partners, SymBiosis, the Cystic Fibrosis Foundation, and the RD Fund (the venture arm of Foundation Fighting Blindness).
-
In the Press
Dr. Thomas Chalberg has been recognized by the Foundation Fighting Blindness for his pioneering contributions to research and development.
-
In Memoriam: Dr. Alan Laties – Early Leader in Retinal Research
Beacon StoriesAlan M. Laties, MD, passed away on Sunday, December 26 at the age of 90.
-
Organizations collaborate on inherited macular dystrophy program
In the PressThe Foundation Fighting Blindness and the Nixon Visions Foundation are working together to launch the Nixon Visions Foundation Inherited Macular Dystrophy Program, according to a news release from the organizations.
-
ProQR Doses First Patients in Phase 2/3 Clinical Trials for its USH2A-Exon 13 RNA Therapy
Research NewsThe Sirius trial is for USH2A (exon 13 mutations) patients with advanced vision loss. The Celeste trial is for USH2A (exon 13 mutations) patients with moderate to early vision loss.
-
Foundation News
Program to have special translational research emphasis on inherited macular dystrophy.
-
Eyes On Eyecare Raises $1,500 for Foundation Fighting Blindness
In the PressOver 1,400 people participated in charitable giving initiative.
-
Ocugen to Launch Clinical Trial for Cross-Cutting RP Gene Therapy
Research NewsThe clinical trial is for RHO and NR2E3 mutations, but the retinal gene therapy has the potential to benefit people with a variety of other mutated genes
-
Beacon Stories
At only three months old, Brendon was diagnosed with x-linked juvenile retinoschisis (XLRS). But with several other family members also with XLRS, Brendon knew he could still follow his passions for science and space. Now 22, Brendon is an Aerospace Engineer, starting a PhD program at UCF, and was recently awarded the prestigious National Science Foundation’s Graduate Research Fellowship.
.png)
